CDR2 anticorps
-
- Antigène Voir toutes CDR2 Anticorps
- CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CDR2 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Recombinant protein of human CDR2
- Isotype
- IgG
- Top Product
- Discover our top product CDR2 Anticorps primaire
-
-
- Indications d'application
- IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.4 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
- Autre désignation
- CDR2 (CDR2 Produits)
- Synonymes
- anticorps CDR62, anticorps Yo, anticorps cdr2, anticorps MGC69206, anticorps CDR2, anticorps AA617262, anticorps RGD1310578, anticorps cerebellar degeneration related protein 2, anticorps cerebellar degeneration related protein 2 L homeolog, anticorps cerebellar degeneration-related 2, anticorps cerebellar degeneration-related protein 2, anticorps cerebellar degeneration related protein 2 like, anticorps CDR2, anticorps cdr2, anticorps cdr2.L, anticorps Cdr2, anticorps CDR2L, anticorps LOC101060399
- Sujet
- CDR2 (cerebellar degeneration-related protein 2), also referred to as Yo or CDR62, is a 545 amino acid protein that is associated with the development of paraneoplastic cerebellar degeneration (PCD). PCD, an immune-mediated syndrome, belongs to a heterogeneous group of rare paraneoplastic neurologic disorders affecting the neurological system. PCD is characterized by subacute cerebellar ataxia and occurs mainly in patients with ovarian, uterine, fallopian tube or breast cancer.
- UniProt
- Q01850
-